Trump’s Testimonial Is a Double-Edged Sword for Regeneron. Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), Clinical Trials, United States Politics and Government, Presidential Election of 2020, Regeneron Pharmaceuticals Inc, Eli Lilly and Company, Trump, Donald J